Fu Su

Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity

Donald B. Axworthy, J. M. Reno, Mark D. Hylarides et al. · Proceedings of the National Academy of Sciences · 2000 · 230 citations

Medicine, Oncology, Pharmacology +17

Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin.

Hazel B. Breitz, Paul L. Weiden, Paul L. Beaumier et al. · PubMed · 2000 · 151 citations

Medicine, Nuclear Medicine, Oncology +17

High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma

Yafei Zhang, Peng Liu, Yizhen Jiang et al. · Pathology & Oncology Research · 2015 · 31 citations

Medicine, Oncology, Pathology +13

¹⁸⁶ Re-Labeled Antibodies to p185 ^HER2 as HER2-Targeted Radioimmunopharmaceutical Agents: Comparison of Physical and Biological Characteristics with ¹²⁵ I and ¹³¹ I-Labeled Counterparts

Claire E. Kotts, Fu Su, Cecilia Leddy et al. · Cancer Biotherapy and Radiopharmaceuticals · 1996 · 17 citations

Medicine, Oncology, Pharmacology +17

Gadolinium-conjugated CB86: a novel TSPO-targeting MRI contrast agent for imaging of rheumatoid arthritis

Zhenyu Hou, Qiang Wang, Zhide Guo et al. · Journal of drug targeting · 2019 · 14 citations

Medicine, Medicinal Chemistry, Pharmaceutics +17